Clinical Trials

Find a Trial

Trial Results

11 protocol(s) meet the specified criteria
A021501OPEN TO ACCRUAL
PREOPERATIVE EXTENDED CHEMOTHERAPY VS. CHEMOTHERAPY PLUS HYPOFRACTIONATED RADIATION THERAPY FOR BORDERLINE RESECTABLE ADENOCARCINOMA OF THE HEAD OF THE PANCREAS
BAY94-9343OPEN TO ACCRUAL
Phase 1b Multi-indication Study of Anetumab Ravtansine (BAY 94-9343)in Patients with Mesothelin Expressing Advanced or Recurrent Malignancies
CANSTEM111POPEN TO ACCRUAL
A Phase III Study of BBI-608 plus nab-Paclitaxel with Gemcitabine in Adult Patients with Metastatic Pancreatic Adenocarcinoma.
IUCRO-0309OPEN TO ACCRUAL
IU Pancreatic Lesion Tissue/Fluid Bank
IUCRO-0454OPEN TO ACCRUAL
Molecular Phenotyping of Pancreatic Cancer Cachexia: A Bridge to Personalized Targeted Therapy
IUCRO-0495OPEN TO ACCRUAL
Creation of a Pancreatic Cancer Outcome Database with Blood Storage
IUSCC-0565OPEN TO ACCRUAL
Pilot study of respiratory-gated stereotactic body radiation therapy for boderline resectable, unresectable, or recurrent/residual adenocarcinoma of the pancreas or periampullary region.
IUSCC-0597OPEN TO ACCRUAL
A phase II trial of cabozantinib and erlotinib for patients with EGFR and c-Met co-expressing metastatic pancreatic adenocarcinoma
IUSCC-0632OPEN TO ACCRUAL
Pilot Study to Examine Correlation of Nab-Paclitaxel/Gemcitabine Pharmacokinetics with Cachexia
RTOG-0848OPEN TO ACCRUAL
A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (PH II-R) and Chemoradiation (PHIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
S1505OPEN TO ACCRUAL
A RANDOMIZED PHASE II STUDY OF PERIOPERATIVE mFOLFIRINOX VERSUS GEMCITABINE/NAB-PACLITAXEL AS THERAPY FOR RESECTABLE PANCREATIC ADENOCARCINOMA